CliffBio
small molecule

NIKKI

DROSPIRENONE; ETHINYL ESTRADIOL

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameNIKKI
Active ingredientDROSPIRENONE; ETHINYL ESTRADIOL
Strength3MG;0.02MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 2014
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.